Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nina E. Osipova"'
Autor:
Boris V. Afanasyev, Ruslana V Kruglina, Igor A. Lisukov, Artur E Zdorov, Gary J Gorodokin, Denis A. Fedorenko, Roman I Ivanov, Alexandr A. Myasnikov, Oleg A. Rykavicin, Tatiana I. Ionova, Anton V. Kishtovich, Andrei A. Novik, Vladimir Y. Melnichenko, Nina E. Osipova
Publikováno v:
Blood. 112:4432-4432
Conventional therapies do not provide satisfactory control of multiple sclerosis (MS) due to their inability to eradicate self-specific T cell clones. During the last decade high-dose immunosuppressive therapy (HDIT) with autologous haematopoietic st
Autor:
Natalia N. Malakchova, Julia K. Lebedeva, Nina E. Osipova, Tatiana I. Ionova, Mikhail V. Kopp, Alexander Myasnikov, Tatiana V. Chagorova, Gary I. Gorodokin, Anton V. Kishtovich, Andrei A. Novik, Denis A. Fedorenko, Anastasia V. Pankova
Publikováno v:
Blood. 106:4651-4651
The population of new ANHL patients is heterogeneous in terms of their biological parameters and the IPI scoring system is widely used to make the disease prognosis. Recently heterogeneity of ANHL patients in terms of their QoL has been shown. There
Autor:
Tatiana I. Ionova, Nina E. Osipova, Denis A. Fedorenko, Olga S. Uspenskaya, Andri A. Novik, Anton V. Kishtovich
Publikováno v:
Blood. 104:3125-3125
Background: It is quite obvious that population of new Hodgkin’s disease (HD) patients is heterogeneous in terms of clinical characteristics. Therefore stratification of patients is necessary to select appropriate treatment regimen. It was shown th